ArticleBiomedical signal processing and control2022
DCML: Deep contrastive mutual learning for COVID-19 recognition.
Article in Biomedical signal processing and control, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A Comprehensive Review of Machine Learning Used to Combat COVID-19.Diagnostics (Basel, Switzerland) · 2022Review
- TiM-Net: Transformer in M-Net for Retinal Vessel Segmentation.Journal of healthcare engineering · 2022Article
- A Parallel Spiking Neural Network Based on Adaptive Lateral Inhibition Mechanism for Objective Recognition.Computational intelligence and neuroscience · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 is a form of disease triggered by a new strain of coronavirus. Automatic COVID-19 recognition using computer-aided methods is beneficial for speeding up diagnosis efficiency. Current researches usually focus on a deeper or wider neural network for COVID-19 recognition. And the implicit contrastive relationship between different samples has not been fully explored. To address these problems, we propose a novel model, called deep contrastive mutual learning (DCML), to diagnose COVID-19 more effectively. A multi-way data augmentation strategy based on Fast AutoAugment (FAA) was employed to enrich the original training dataset, which helps reduce the risk of overfitting. Then, we incorporated the popular contrastive learning idea into the conventional deep mutual learning (DML) framework to mine the relationship between diverse samples and created more discriminative image features through a new adaptive model fusion method. Experimental results on three public datasets demonstrate that the DCML model outperforms other state-of-the-art baselines. More importantly, DCML is easier to reproduce and relatively efficient, strengthening its high practicality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.